First Time Loading...

Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.165 CAD 3.13% Market Closed
Updated: May 7, 2024

Theralase Technologies Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theralase Technologies Inc
Operating Income Peer Comparison

Comparables:
NVCN
PRN
OPS
NSCI
MIR

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Theralase Technologies Inc
XTSX:TLT
Operating Income
-CA$4.6m
CAGR 3-Years
7%
CAGR 5-Years
-6%
CAGR 10-Years
-15%
Neovasc Inc
TSX:NVCN
Operating Income
-$33.2m
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-21%
Profound Medical Corp
TSX:PRN
Operating Income
-$28.6m
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Opsens Inc
TSX:OPS
Operating Income
-CA$12.5m
CAGR 3-Years
-86%
CAGR 5-Years
-25%
CAGR 10-Years
-19%
Nanalysis Scientific Corp
XTSX:NSCI
Operating Income
-CA$10.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedMira Inc
XTSX:MIR
Operating Income
-CA$2.2m
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
3%

See Also

What is Theralase Technologies Inc's Operating Income?
Operating Income
-4.6m CAD

Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Operating Income amounts to -4.6m CAD.

What is Theralase Technologies Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-15%

Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Theralase Technologies Inc have been 7% over the past three years , -6% over the past five years , and -15% over the past ten years .